Is Medicago USA Monsanto's Ugly Cousin???

Medicago USA

Medicago USA., a wholly owned subsidiary of Medicago Inc., has completed the construction of its commercial-scale facility in Research Triangle Park (RTP), North Carolina. This Virus-Like-Particle plant-based vaccine facility includes a fully automated greenhouse, customized infiltration systems, and a state of the art extraction and purification unit. The 97,000-square-foot facility is targeted to produce 10 million doses of pandemic influenza vaccine per month. On an annual basis, the facility is expected to have production capacity of 30 million doses of quadrivalent seasonal influenza vaccine or 120 million doses of pandemic influenza vaccine.

http://www.medicago.com/English/Medicago-USA/MedicagoUSA/default.aspx


What's the Blue Angel program about? Tweet